Clinical trial
Clinical Pharmacogenomics of Antidepressant Response
NCT00269334 · National Health Research Institutes, Taiwan, Other · Unknown status
Key facts
| NCT number | NCT00269334 |
|---|---|
| Title | Clinical Pharmacogenomics of Antidepressant Response |
| Official title | Phase 4 Study of Clinical Pharmacogenomics of Antidepressant Response |
| Lead sponsor | National Health Research Institutes, Taiwan, Other |
| Collaborators | National Science and Technology Council, Taiwan Taipei Medical University WanFang Hospital Chang Gung Memorial Hospital Jing-Ho Mental Hospital, Taiwan Tsyr-Huey Mental Hospital |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Major Depression |
| Intervention type | Drug |
| Interventions | Using Citalopram(drug) or Paroxetine(drug) |
| Enrollment | 400 |
| Start date | Dec 1, 2005 |
| Completion | Nov 1, 2007 |
| First posted | Dec 23, 2005 |
| Last update posted | Dec 23, 2005 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: